Triphenylethylene compounds and uses thereof
US9845295B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 2016 |
| Grant date | Dec 19, 2017 |
| Priority date | — |
| Expiry date | Nov 22, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Triphenylethylene compounds of formula (II)as dual aromatase inhibitors and selective estrogen receptors modulators are described. Also described are methods for treating patients of breast cancers, and patients of breast cancer comorbid with osteoporosis, using the described triphenylethylence compounds or pharmaceutical formulations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.